Stay updated on Nivolumab ± Ipilimumab in Ovarian Cancer Clinical Trial

Sign up to get notified when there's something new on the Nivolumab ± Ipilimumab in Ovarian Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab ± Ipilimumab in Ovarian Cancer Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    Change Detected
    Summary
    No substantive changes detected; observed updates appear limited to minor UI text tweaks and the page's last updated timestamp, with core study content, eligibility criteria, primary outcomes, and locations remaining the same. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-03T01:10:29.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    38 days ago
    Change Detected
    Summary
    Major update: page now includes a government funding status notice and indicates version 3.2.0, replacing the previous 3.1.0.
    Difference
    1%
    Check dated 2025-10-05T09:34:17.000Z thumbnail image
  5. Check
    46 days ago
    Change Detected
    Summary
    The page shifts from detailed cancer histology terms to broader immunology-related topics and updates to a new revision (v3.1.0), removing several cancer-specific classifications (v3.0.2).
    Difference
    2%
    Check dated 2025-09-28T03:06:42.000Z thumbnail image
  6. Check
    60 days ago
    Change Detected
    Summary
    Updated the page to Revision v3.0.2 from v3.0.1, and removed the old 'Back to Top' element.
    Difference
    0.1%
    Check dated 2025-09-13T16:47:28.000Z thumbnail image
  7. Check
    67 days ago
    Change Detected
    Summary
    The page has been updated to reflect a new version, v3.0.1, indicating a recent revision. The previous version, v3.0.0, has been removed from the page.
    Difference
    0.1%
    Check dated 2025-09-06T14:10:05.000Z thumbnail image
  8. Check
    74 days ago
    Change Detected
    Summary
    The web page has been updated to include new facility names and locations, as well as specific medical terms related to ovarian cancer, while removing outdated location details and certain genetic resources.
    Difference
    4%
    Check dated 2025-08-30T11:07:31.000Z thumbnail image

Stay in the know with updates to Nivolumab ± Ipilimumab in Ovarian Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab ± Ipilimumab in Ovarian Cancer Clinical Trial page.